Atlas Trials

The Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Vaccine

Clinical trial NCT02592486 · COMPLETED

Trial details

NCT number
NCT02592486
Sponsor
Kameda Medical Center
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Pneumococcal PneumoniaInfluenza
Start date
2015-11-01
Primary completion
2016-03-01
Enrollment
162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.